Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 362
5
Diseases
22
Unique genes
0.247
Avg. similarity score
Chromosome 15q24 deletion syndrome
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Chromosome 15q24 deletion syndrome
SIN3A-related intellectual disability syndrome
Witteveen-kolk syndrome
15q24 microdeletion
Congenital diaphragmatic hernia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Chromosome 15q24 deletion syndrome | 4 | 4 | 1 |
| SIN3A-related intellectual disability syndrome | 4 | 4 | 1 |
| Witteveen-kolk syndrome | 4 | 4 | 2 |
| 15q24 microdeletion | 3 | 3 | 2 |
| Congenital diaphragmatic hernia | 3 | 3 | 20 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SIN3A | 5 / 5 | 15q24 microdeletion, Chromosome 15q24 deletion syndrome, Congenital diaphragmatic hernia, SIN3A-related intellectual disability syndrome and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ECM-receptor interaction | KEGG | 3 / 89 | 18.4× | 5.47e-4 | 8.53e-3 ✓ sig. |
| Regulation of lipid metabolism by PPARalpha | Reactome | 2 / 20 | 54.6× | 5.97e-4 | 9.15e-3 ✓ sig. |
| Transcriptional misregulation in cancer | KEGG | 3 / 198 | 8.3× | 5.39e-3 | 4.60e-2 ✓ sig. |
| Loss of MECP2 binding ability to 5mC-DNA | Reactome | 1 / 3 | 182× | 5.49e-3 | 4.65e-2 ✓ sig. |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | Reactome | 1 / 3 | 182× | 5.49e-3 | 4.65e-2 ✓ sig. |
| MET activates STAT3 | Reactome | 1 / 3 | 182× | 5.49e-3 | 4.65e-2 ✓ sig. |
| MECP2 regulates neuronal receptors and channels | Reactome | 1 / 4 | 136× | 7.31e-3 | 5.62e-2 |
| MET activates PTPN11 | Reactome | 1 / 5 | 109× | 9.13e-3 | 6.50e-2 |
| MET interacts with TNS proteins | Reactome | 1 / 5 | 109× | 9.13e-3 | 6.50e-2 |
| MET Receptor Activation | Reactome | 1 / 6 | 91.0× | 1.09e-2 | 7.25e-2 |
| MET activates PI3K/AKT signaling | Reactome | 1 / 6 | 91.0× | 1.09e-2 | 7.25e-2 |
| Regulation of MECP2 expression and activity | Reactome | 1 / 6 | 91.0× | 1.09e-2 | 7.25e-2 |
| InlB-mediated entry of Listeria monocytogenes into host cell | Reactome | 1 / 7 | 78.0× | 1.28e-2 | 7.89e-2 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | Reactome | 2 / 97 | 11.3× | 1.34e-2 | 8.14e-2 |
| Factors involved in megakaryocyte development and platelet production | Reactome | 2 / 99 | 11.0× | 1.40e-2 | 8.34e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| anatomical structure morphogenesis | GO:0009653 | 6 / 160 | 31.9× | 2.39e-8 | 3.64e-6 ✓ sig. |
| positive regulation of cardiac muscle myoblast proliferation | GO:0110024 | 2 / 3 | 566× | 3.97e-6 | 2.49e-4 ✓ sig. |
| pancreas development | GO:0031016 | 3 / 30 | 84.9× | 5.63e-6 | 3.30e-4 ✓ sig. |
| metanephros development | GO:0001656 | 3 / 38 | 67.1× | 1.16e-5 | 5.86e-4 ✓ sig. |
| heart development | GO:0007507 | 5 / 273 | 15.6× | 1.38e-5 | 6.71e-4 ✓ sig. |
| ventricular septum morphogenesis | GO:0060412 | 3 / 41 | 62.2× | 1.47e-5 | 7.04e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 8 / 1,208 | 5.6× | 4.21e-5 | 1.58e-3 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 7 / 1,002 | 5.9× | 1.05e-4 | 3.12e-3 ✓ sig. |
| cell communication | GO:0007154 | 3 / 80 | 31.9× | 1.10e-4 | 3.24e-3 ✓ sig. |
| response to growth factor | GO:0070848 | 2 / 14 | 121× | 1.19e-4 | 3.46e-3 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 8 / 1,454 | 4.7× | 1.57e-4 | 4.23e-3 ✓ sig. |
| in utero embryonic development | GO:0001701 | 4 / 252 | 13.5× | 1.95e-4 | 4.96e-3 ✓ sig. |
| embryonic digestive tract morphogenesis | GO:0048557 | 2 / 18 | 94.4× | 2.00e-4 | 5.05e-3 ✓ sig. |
| animal organ development | GO:0048513 | 3 / 102 | 25.0× | 2.25e-4 | 5.48e-3 ✓ sig. |
| lung development | GO:0030324 | 3 / 108 | 23.6× | 2.67e-4 | 6.20e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Chromosome 15q24 deletion syndrome | SIN3A-related intellectual disability syndrome | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| 15q24 microdeletion | Chromosome 15q24 deletion syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| 15q24 microdeletion | SIN3A-related intellectual disability syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Chromosome 15q24 deletion syndrome | Witteveen-kolk syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| SIN3A-related intellectual disability syndrome | Witteveen-kolk syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| 15q24 microdeletion | Witteveen-kolk syndrome | 0.250 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Chromosome 15q24 deletion syndrome | Congenital diaphragmatic hernia | 0.048 | 1 | 1.30e-3 | 2.04e-3 ✓ sig. |
| Congenital diaphragmatic hernia | SIN3A-related intellectual disability syndrome | 0.048 | 1 | 1.30e-3 | 2.04e-3 ✓ sig. |
| Congenital diaphragmatic hernia | Witteveen-kolk syndrome | 0.045 | 1 | 2.60e-3 | 3.50e-3 ✓ sig. |